Sell Out
Sell Out data allows manufacturers to conduct audits, analyze demand for goods by city and region, study the consumption of medical products and goods by the population, and evaluate the effectiveness of marketing activities.

Speed monthly on the 15th day
#1 in Kazakhstan
Accuracy- more than 75% market
No. 1 in the EAEU
Geography – Country/Regions/Cities
Coverage – more than 6000 operating pharmacies
Sell Out
Manufacturers need data across the entire market, not just reports from contracted pharmacy chains. Limited Sell Out data prevents them from seeing the full picture of consumption, making it difficult to develop effective strategies and scale up their business.
The Vi-ORTIS Sell Out analysis will help the manufacturer understand the movement of the drug and answer questions:

Level of consumer demand

Effectiveness of advertising and marketing activities

Seasonality of drug consumption

Competitors' sales dynamics
About the product
The product contains 9 product categories
● Medicines
● Mother and child products
● Baby food
● IMN
● Personal hygiene products
● Medicinal herbs
● Dietary supplement
● BC funds
● Medical cosmetics
Sell Out
Why do they
trust SELL OUT
Data sources
- ●Pharmacy chains: — 100 networks (2600 drugstores)
- ●Individual pharmacies:more than 1000 pharmacies
- ●PharmIT:Medical Representative Office over 5000
- ●PharmIT:PharmCenter more than 3500 active pharmacies
- ●Vi-ORTIS 3.0:analytical system within a pharmacy chain, more than 20 chains (500 pharmacy outlets)
- ● OFD: Checks from Kazakhtelecom (more than 800 pharmacies)
Sell Out from base.viortis displays data on the number of drugs purchased by the population in pharmacies.
The product allows you to track the movement of goods in the channel.
Five-stage data processing system

1. Input
- Checking the completeness and quality of the received data,
Monthly data entry in electronic form - Direct integration with pharmacies
- Sales details for drugstores

2. Classification of shipping points
- Standardization of pharmacy outlets according to internal reference books

3. Comparison
- Comparison of drugs, spelling of names, manufacturers according to internal reference books and the state register

4. Extrapolation
- Extrapolation at the regional level
- The methodology has been approved by analysts from Vi-ORTIS

5. Quality control
- Comparison of the total amount of the original file with the final data after processing and recalculation
- Checking the TOP-30 products by key parameters: amount and number of packages
Sell Out
Sell Out from base.viortis displays data on the number of drugs purchased by the population in pharmacies. The product allows you to track the movement of goods in the sales channel, which is clearly demonstrated by the diagram below


Technical specifications
● 5 currencies: tenge, dollar, euro, ruble, pound sterling
● Competitors price analysis min/max
● ATC code EphMRA- 3 levels
● ICD - International Classification of Diseases
● INN - active substance
● Core market
● NFC - New Form Classification
● My Report: Saving Custom Reports
● Unlimited number of users
● Evolution index - sum/pack
● Average price/unit price
● Price change index

Analytical and IT EcoSystem of products
Vi-ORTIS
Vi-ORTIS is the only domestic company providing a full range of analytical and IT services in the pharmaceutical market.
Why do manufacturers choose
Sell Out
Service
- Microsoft Power BI integration
- Personal technical manager
- Quarterly Pharmaceutical Market REVIEWS
- 5 years of data archive

Accuracy
- Over 75% market
No. 1 in the EAEU
Geography
- Country
- 17 regions
- 18 cities
Speed
- Monthly - on the 15th day
#1 in Kazakhstan

Methodology
- Sell Out Vi-ORTIS uses a unique methodology, taking into account the market conditions of Kazakhstan

Price
- Flexible pricing policy
- Vi-ORTIS products are a constructor.

WE ARE TRUSTED












video gallery
NEWS
All news

Innovation Awards
Vi-ortis received the award for the best product of the year in the category "innovative solutions for health" at the exhibition of health and technology
Read the full article
08.10.2024
